The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Open accessAbstract
BACKGROUND: Primary hyperaldosteronism is a well-recognized cause of secondary hypertension. It is unknown whether serum aldosterone levels within the physiologic range influence the risk of hypertension. METHODS: We investigated the relation of baseline serum aldosterone levels to increases in blood pressure and the incidence of hypertension after four years in 1688 nonhypertensive participants in the Framingham Offspring Study (mean age, 55 years), 58 percent of whom were women. We defined an increase in blood pressure as an increment of at least one blood-pressure category (as defined by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) and defined hypertension as a systolic blood pressure of 140 mm Hg or higher, a diastolic blood pressure of 90 mm Hg or higher, or the use of antihypertensive medications. RESULTS: At follow-up, the blood-pressure category had increased in 33.6 percent of the participants, and hypertension had developed in 14.8 percent. In multivariable models, a 16 percent increase in the risk of an elevation in blood pressure (P=0.002) and a 17 percent increase in the risk of hypertension (P=0.03) were observed per quartile increment in the serum aldosterone level. The highest serum aldosterone quartile, relative to the lowest, was associated with a 1.60-fold risk of an elevation in blood pressure (95 percent confidence interval, 1.19 to 2.14) and a 1.61-fold risk of hypertension (95 percent confidence interval, 1.05 to 2.46). The associations between the serum aldosterone level and blood-pressure outcomes were not significantly affected by adjustment for urinary sodium excretion or left ventricular thickness or internal dimensions. CONCLUSIONS: In our community-based sample, increased aldosterone levels within the physiologic range predisposed persons to the development of hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Best Subsets Logistic Regression
Hosmer, D. W., Jovanovic, B., & Lemeshow, S. (1989) · Biometrics · doi:10.2307/2531779 · Cited by 1,176
Vasan, R. S., Larson, M. G., Leip, E. P., Kannel, W. B., & Levy, D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06710-1 · Cited by 1,072
Self-citationMolecular Genetics of Human Blood Pressure Variation
Lifton, R. P. (1996) · Science · doi:10.1126/science.272.5262.676 · Cited by 629
Oliver, W. J., Cohen, E. L., & Neel, J. V. (1975) · Circulation · doi:10.1161/01.cir.52.1.146 · Cited by 539
Hatakeyama, H., Miyamori, I., Fujita, T., Takeda, Y., Takeda, R., & Yamamoto, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51084-5 · Cited by 316
Cited by
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Sodium and Potassium in the Pathogenesis of Hypertension
Adrogué, H. J., & Madias, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064486 · Cited by 763
Hypertension: Renin–Angiotensin–Aldosterone System Alterations
te Riet, L., van Esch, J. H. M., Roks, A. J. M., van den Meiracker, A. H., & Danser, A. H. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303587 · Cited by 706
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study
Brown, J. M., Siddiqui, M., Calhoun, D. A., Carey, R. M., Hopkins, P. N., Williams, G. H., & Vaidya, A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0065 · Cited by 649
Renal Damage in Primary Aldosteronism: Results of the PAPY Study
Rossi, G. P., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Matterello, M.-J., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000230444.01215.6a · Cited by 470
The Evidence for a Narrower Thyrotropin Reference Range Is Compelling
Wartofsky, L., & Dickey, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0455 · Cited by 424
Vascular Endothelial Function and Hypertension: Insights and Directions
Dharmashankar, K., & Widlansky, M. E. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0150-2 · Cited by 424
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
The new biology of aldosterone
Connell, J. M. C., & Davies, E. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06017 · Cited by 356
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Adler, G. K., Stowasser, M., Correa, R. R., Khan, N., Kline, G., McGowan, M. J., Mulatero, P., Murad, M. H., Touyz, R. M., Vaidya, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf284 · Cited by 355
Pratt-Ubunama, M. N., Nishizaka, M. K., Boedefeld, R. L., Cofield, S. S., Harding, S. M., & Calhoun, D. A. (2007) · Chest · doi:10.1378/chest.06-1442 · Cited by 331
Gaddam, K. K. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1159 · Cited by 301
Vaidya, A., Mulatero, P., Baudrand, R., & Adler, G. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00139 · Cited by 299
Forrest, M. J., Bloomfield, D., Briscoe, R. J., Brown, P. N., Cumiskey, A., Ehrhart, J., Hershey, J. C., Keller, W. J., Ma, X., McPherson, H. E., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.229 · Cited by 292
Caprio, M., Newfell, B. G., la Sala, A., Baur, W., Fabbri, A., Rosano, G., Mendelsohn, M. E., & Jaffe, I. Z. (2008) · Circulation Research · doi:10.1161/circresaha.108.174235 · Cited by 285
Parthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455ca5 · Cited by 281
Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry
Reincke, M., Fischer, E., Gerum, S., Merkle, K., Schulz, S., Pallauf, A., Quinkler, M., Hanslik, G., Lang, K., Hahner, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197111 · Cited by 278
Plasma aldosterone is independently associated with the metabolic syndrome
Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231338.41548.fc · Cited by 226
Calhoun, D. A., White, W. B., Krum, H., Guo, W., Bermann, G., Trapani, A., Lefkowitz, M. P., & Ménard, J. (2011) · Circulation · doi:10.1161/circulationaha.111.029892 · Cited by 227
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study
Brown, J. M., Robinson-Cohen, C., Luque-Fernandez, M. A., Allison, M. A., Baudrand, R., Ix, J. H., Kestenbaum, B., de Boer, I. H., & Vaidya, A. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0882 · Cited by 221
Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0030 · Cited by 182
Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155
Vaidya, A., & Williams, J. S. (2012) · Metabolism · doi:10.1016/j.metabol.2011.09.007 · Cited by 151
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome
Cascella, T., Palomba, S., Tauchmanovà, L., Manguso, F., Di Biase, S., Labella, D., Giallauria, F., Vigorito, C., Colao, A., Lombardi, G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0399 · Cited by 120
Effects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114
Markou, A., Pappa, T., Kaltsas, G., Gouli, A., Mitsakis, K., Tsounas, P., Prevoli, A., Tsiavos, V., Papanastasiou, L., Zografos, G., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3353 · Cited by 112
Short sleep duration and increased risk of hypertension: a primary care medicine investigation
Faraut, B., Touchette, É., Gamble, H., Royant-Parola, S., Safar, M. E., Varsat, B., & Léger, D. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835465e5 · Cited by 109
Hyperaldosteronism as a Common Cause of Resistant Hypertension
Calhoun, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-135929 · Cited by 108
Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension
Karns, A. D., Bral, J. M., Hartman, D., Peppard, T., & Schumacher, C. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12051 · Cited by 104
Pathophysiology of salt sensitivity hypertension
Ando, K., & Fujita, T. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.671538 · Cited by 61
The multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
Luo, P., Dematteo, A., Wang, Z., Zhu, L., Wang, A., Kim, H.-S., Pozzi, A., Stafford, J. M., & Luther, J. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2814-8 · Cited by 41
Byrd, J. B., & Brook, R. D. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.42 · Cited by 25
Grübler, M. R., Kienreich, K., Gaksch, M., Verheyen, N., Hartaigh, B. Ó., Fahrleitner-Pammer, A., März, W., Schmid, J., Oberreither, E.-M., Wetzel, J., et al. (2016) · Medicine · doi:10.1097/md.0000000000002794 · Cited by 13
Aldosterone Synthase Inhibition in Hypertension
Andersen, K. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0379-7 · Cited by 12
Circulating aldosterone and mortality in female nursing home residents
Tomaschitz, A., Pilz, S., Pieske, B., Ritz, E., März, W., Meinitzer, A., Dobnig, H., Amrein, K., Kienreich, K., Verheyen, N., et al. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.01.004 · Cited by 7
Metadata
- Authors
- Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-07
- Volume
- 351
- Issue
- 1
- Pages
- 33-41
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2098519186
- Cited by
- 571
- References
- 37
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.